Austin, Texas
United States
78
2026-05-14
The entities that hold a legal rights for patent applications filed by inventor Simard John:
John Simard from Austin, US has applied for patents for these inventions. The list has both pending applications and granted patents:
True human antibody specific for interleukin 1 alpha
#2 | 2026-05-14True human antibody specific for interleukin 1 alpha
#3 | 2026-05-14True human antibody specific for interleukin 1 alpha
#4 | 2026-05-07Herpes Zoster Treatment
#5 | 2025-02-13Arthritis Treatment
#6 | 2024-02-01HUMAN ANTIBODY SPECIFIC FOR INTERLEUKIN-1ALPHA
#7 | 2024-01-11Compositions and methods for treating and preventing staphylococcus aureus infections
#8 | 2023-11-30Treatment for neoplastic diseases
#9 | 2023-10-12True human antibody specific for interleukin 1 alpha
#10 | 2023-09-14True human antibody specific for interleukin 1 alpha
#11 | 2023-09-14True human antibody specific for interleukin 1 alpha
#12 | 2023-09-14True human antibody specific for interleukin 1 alpha
#13 | 2022-11-17Arthritis treatment
#14 | 2022-08-11Compositions and methods for treating and preventing infections
#15 | 2022-07-14ANTIBODY FORMULATION
#16 | 2022-03-03TREATMENT OF PSYCHIATRIC CONDITIONS
#17 | 2022-02-10Treatment of brain ischemia-reperfusion injury
#18 | 2021-12-30TREATING VASCULAR DISEASE AND COMPLICATIONS THEREOF
#19 | 2021-08-05TREATMENT OF ATOPIC DERMATITIS
#20 | 2021-06-10HUMAN ANTIBODY SPECIFIC FOR INTERLEUKIN-1ALPHA
#21 | 2021-01-21Compositions and Methods for Treating and Preventing Staphylococcus Aureus Infections
#22 | 2020-04-30Compositions and methods for treating and preventing infections
#23 | 2020-03-05Immunoglobulin Variable Region Libraries
#24 | 2019-11-21Arthritis treatment
#25 | 2019-06-06TREATMENT OF CANCER WITH ANTI-IL-1 ALPHA ANTIBODIES
#26 | 2019-05-02Treatment for neoplastic diseases
#27 | 2019-05-02Compositions and methods for treating and preventing infections
#28 | 2018-12-20Treatment of psychiatric conditions
#29 | 2018-05-10Human antibody specific for interleukin-1 alpha
#30 | 2018-03-01TREATING VASCULAR DISEASE AND COMPLICATIONS THEREOF
#31 | 2018-02-08Cachexia treatment
#32 | 2017-12-07Compositions and methods for treating and preventing infections
#33 | 2017-08-17Immunoglobulin Variable Region Libraries
#34 | 2017-03-23Treatment of diabetes
#35 | 2017-01-19Compositions and methods for treating and preventing infections
#36 | 2017-01-05Arthritis Treatment
#37 | 2016-12-22Treatment of dermatological pathologies
#38 | 2016-12-15Immunoglobulin variable region libraries
#39 | 2016-09-29Compositions and methods for treating and preventing infections
#40 | 2016-06-09TREATMENT OF CANCER WITH ANTI-IL-1 ALPHA ANTIBODIES
#41 | 2016-03-03Identifying affinity-matured human antibodies
#42 | 2016-03-03Identifying affinity-matured human antibodies
#43 | 2016-01-28Human antibody specific for interleukin-1alpha
#44 | 2015-12-03Compositions and methods for treating and preventing infections
#45 | 2015-04-02Human antibody specific for IL-1alpha
#46 | 2014-07-03Nucleic acids encoding a human monoclonal antibody that specifically binds to IL-1α
#47 | 2014-04-10TREATING VASCULAR DISEASE AND COMPLICATIONS THEREOF
#48 | 2014-03-27Treatment of diabetes
#49 | 2013-10-31Treatment of Psychiatric Conditions
#50 | 2013-08-01TREATMENT OF CACHEXIA BY TARGETING INTERLEUKIN-1 BETA
#51 | 2013-07-11Method for killing IL-1 alpha expressing cells
#52 | 2013-07-04Inhibiting cell migration
#53 | 2013-03-28Cachexia treatment
#54 | 2013-02-14Treatment of inflammatory skin disease
#55 | 2013-01-17Identifying affinity-matured human antibodies
#56 | 2012-11-01Modulation of pathogenic CD14+/CD16+ monocytes
#57 | 2012-10-04Treatment of Dermatological Pathologies
#58 | 2012-09-13Increasing anti-IL-1α antibodies in a subject
#59 | 2012-06-28Interleukin-1 Alpha Antibodies and Methods of Use
#60 | 2012-05-10IL-1alpha immunization induces autoantibodies protective against atherosclerosis
#61 | 2012-04-19Methods for identifying a subject who has developed an anti-antibody response
#62 | 2012-04-19Characterizing an allotypic phenotype of a subject
#63 | 2012-02-23Treatment for neoplastic diseases
#64 | 2012-01-26Interleukin-1 Alpha Antibodies and Methods of Use
#65 | 2012-01-19Interleukin-1 alpha antibodies and methods of use
#66 | 2012-01-19Interleukin-1α antibodies and methods of use
#67 | 2012-01-19Interleukin-1 alpha antibodies and methods of use
#68 | 2011-12-22Arthritis Treatment
#69 | 2011-03-24Method of modifying a monoclonal antibody
#70 | 2011-03-24Panel of monoclonal antibody containing pharmaceutical compositions
#71 | 2011-03-24Method and devices for identifying and treating a subject who has developed an anti-antibody response
#72 | 2011-03-24Method of selecting a monoclonal antibody for administration
#73 | 2011-01-13IL-1alpha immunization induces autoantibodies protective against atherosclerosis
#74 | 2010-03-18Modulation of the amount or function of pathogenic CD14+CD16+ monocytes
#75 | 2010-02-18TREATMENT OF CANCER WITH ANTI-IL-1alpha ANTIBODIES
#76 | 2009-12-03Interleukin-1α antibodies
#77 | 2009-07-30IL-1alpha IMMUNIZATION INDUCES AUTOANTIBODIES PROTECTIVE AGAINST ATHEROSCLEROSIS
#78 | 2009-05-14Diagnosis, treatment, and prevention of vascular disorders using IL-1 autoantibodies
42848 ⎘